Felix González-López de Turiso
Bristol-Myers Squibb (United States)(US)
Publications by Year
Research Areas
Synthetic Organic Chemistry Methods, PI3K/AKT/mTOR signaling in cancer, Click Chemistry and Applications, Synthesis and biological activity, Radical Photochemical Reactions
Most-Cited Works
- → Discovery of AMG 232, a Potent, Selective, and Orally Bioavailable MDM2–p53 Inhibitor in Clinical Development(2014)291 cited
- → Structure-Based Design of Novel Inhibitors of the MDM2–p53 Interaction(2012)167 cited
- → Radical Cyclization Approach to Spirocyclohexadienones(2004)116 cited
- → Discovery and in Vivo Evaluation of (S)-N-(1-(7-Fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9H-purin-6-amine (AMG319) and Related PI3Kδ Inhibitors for Inflammation and Autoimmune Disease(2014)85 cited
- → Rational Design and Binding Mode Duality of MDM2–p53 Inhibitors(2013)84 cited
- → Synthetic studies towards furanocembrane diterpenes. A total synthesis of bis-deoxylophotoxin(2005)52 cited
- → Discovery and in Vivo Evaluation of Dual PI3Kβ/δ Inhibitors(2012)49 cited
- → Concise synthesis of stereodefined, thiazole—containing cyclic hexa- and octapeptide relatives of the Lissoclinums, via cyclooligomerisation reactions(2003)43 cited
- → Rational Design and Optimization of a Novel Class of Macrocyclic Apoptosis Signal-Regulating Kinase 1 Inhibitors(2019)34 cited
- → Discovery of AMG 853, a CRTH2 and DP Dual Antagonist(2011)33 cited